UPP1 and glioblastoma: In addition, we used the SurvExpress analysis to further assess the prognostic value of TIMP1, ITGA5, FCGR2B, UPP1, ISG20, TSPAN4, and LOXL1 using other glioblastoma patient cohorts, including TCGA Glioblastoma and GSE4412.